Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02917694
Other study ID # 209899
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2016
Est. completion date May 5, 2018

Study information

Verified date May 2018
Source Oxford University Hospitals NHS Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to assess the feasibility of obtaining details about a patients previous level of function from the patient of friend/relative, after they have been admitted an intensive care unit (ICU). It will also assess the feasibility of re-assessing level of function at 6 months after the patient has been discharged from ICU.


Description:

Currently there is no standardised way of obtaining details about a patients pre-admission level of function. the process of gaining this history is often done by several different people with no standard questions asked.

There is also a need to be able to measure what happens to patients after they leave ICU, and compare their abilities to preadmission status.

This feasibility study will aim to investigate:

- the time taken to train the physiotherapy team in the use of the outcome measure

- the ability to obtain pre admission functional status from patients/friend/relative on admission to ICU

- the ability to follow patients up at 6 months post discharge with re-assessment of the outcome measure


Recruitment information / eligibility

Status Completed
Enrollment 57
Est. completion date May 5, 2018
Est. primary completion date May 5, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Participant is willing and able to give informed consent for participation in the study

- Participants relative or friend (consultee) is willing and able to give informed consent for participation in the study (where the patient is unable to give informed consent)

- Male or Female, aged 18 years or above

- Injury Severity Score greater than 9

- Admitted as an emergency to AICU

- Experienced at least 24 hours level three care during their admission

Exclusion Criteria:

- Non UK resident (due to potential loss to follow up)

- Unwilling to consent

- No GP details available

- Patients with a palliative diagnosis or established on a palliative treatment pathway

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom John Radcliffe Hospital Oxford

Sponsors (1)

Lead Sponsor Collaborator
Oxford University Hospitals NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary WHODAS 2.0 completion rate Number of questionnaires completed/returned on admission to ICU 2 days
Secondary Time to questionnaire completion rate The time taken (hours) from ICU admission to complete the questionnaire 2 days
Secondary WHODAS 2.0 completion rate Number of questionnaires completed/returned at 6 months post ICU discharge 6 months post ICU discharge
See also
  Status Clinical Trial Phase
Recruiting NCT02682550 - Danger Response in Polytrauma Patients N/A
Completed NCT03634215 - Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma
Completed NCT01669577 - Independent Predictors of Mortality in Polytrauma Patients Phase 3
Completed NCT00872690 - Factors Affecting Return to Work Among OEF/OIF Veterans With Polytrauma N/A
Recruiting NCT04588311 - ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients Phase 3
Terminated NCT00613392 - Antioxidant Supplementation in Trauma Patients Phase 3
Recruiting NCT05386199 - The Role of Serotonin in Intensive Care Patients
Recruiting NCT02727946 - Tissue Perfusion Indices as Predictor of Outcome in Poly Trauma Patients N/A
Completed NCT03480555 - Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients N/A
Recruiting NCT03368092 - Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma Phase 3
Recruiting NCT01240291 - The Clinical Role of Intravenous Glutamine in Trauma Patients Receiving Enteral Nutrition Phase 3
Not yet recruiting NCT01074112 - Keller Prehospital Ultrasound Study N/A
Completed NCT00163826 - Spinal Clearance Study: Expediting the Spinal Clearance Process in the Major Trauma Patient Phase 4
Completed NCT05630222 - Evaluation of Effect of Intravenous Morphine vs Intravenous Ibuprofen and Acetaminophen vs Intravenous Ibuprofen Phase 3
Terminated NCT03489577 - The Role of Post-traumatic Inhibition of the Innate and Adaptive Immune System in the Development of Infectious Complications in Severely Injured Patients
Terminated NCT01477697 - Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients Phase 1/Phase 2
Completed NCT01373996 - Clinical Investigation of Wireless Transmission of Invasive Blood Pressure Signal N/A
Completed NCT03154424 - Dynamic External Fixation in Treatment Distal Radius Fractures - Elderly Patients N/A
Recruiting NCT00459160 - A Comparison of Two Target Mean Arterial Pressures in the Resuscitation of Hypotensive Trauma Patients N/A
Recruiting NCT00622934 - Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients Phase 2